Founder and Partner of Kleiner Perkins
Brook Byers is a founding member of Kleiner Perkins, a Silicon Valley based venture capital firm that has helped entrepreneurs build over 600 companies with over 500,000 employees. A venture capital investor since 1972, Brook has been closely involved helping build more than 60 new technology-based ventures, many of which have become public companies.
He formed the first life sciences practice group in the venture capital profession in 1984 and led KP to become a premier venture capital firm in the medical, healthcare and biotechnology sectors. Brook has been an innovator in precision medicine and health genomics, antibodies and devices. He was the founding president and then chairman of four biotechnology companies that were incubated in KP’s offices and went on to become public companies with an aggregate market value of more than US $8 billion. He serves on the board of directors of Epiodyne, Enjoy, Grail, Newsela, Octave and Verana Health.